Factores de riesgo relativos para la erosión cardíaca después del cierre transcatéter de los defectos del septo

Doff B McElhinney1, Michael D Quartermain1, Damien Kenny1

  • 1From Department of Cardiothoracic Surgery, Lucille Packard Children's Hospital, Stanford University, CA (D.B.M.); Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, NC (M.D.Q.); Our Lady's Hospital for Sick Children, Crumlin, Dublin, Ireland (D.K.); Division of Pediatric Cardiology, Banner Children's Specialists, Mesa, AZ (E.A.); and Department of Pediatrics, Children's Hospital of Georgia, Georgia Regents University, Augusta (Z.A.).

Circulation
|March 23, 2016
PubMed
Resumen

El cierre transcatéter de los defectos del tabique auricular (TSA) con el bloqueador de tabique de Amplatzer tiene riesgos de erosión raros pero graves. Los factores clave incluyen la deficiencia del borde aórtico y los dispositivos de gran tamaño, lo que requiere una mayor investigación para mitigar el riesgo.

Videos de Conceptos Relacionados

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...